Litcius/Paper detail

Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients

Emmanuel J. Favaloro, Joanne Clifford, Emma Leitinger, Michael D. Parker, Pauline Sung, Sanjeev Chunilal, Huyen Tran, Geoffrey Kershaw, Suki Fu, Freda Passam, Monica Ahuja, Shir‐Jing Ho, Elizabeth Duncan, Olivia Yacoub, Chee Wee Tan, Lisa Kaminskis, Natasha Modica, Dominic Pepperell, Leanne Ballard, Lisa Clarke, Christine S.M. Lee, Elizabeth E. Gardiner, Philip Choi, Ibrahim Tohidi‐Esfahani, Robert Bird, Timothy Brighton, Vivien Chen

2022Journal of Thrombosis and Haemostasis29 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntibodyImmunologyPlateletFlow cytometryPlatelet factor 4Internal medicineHeparin-Induced Thrombocytopenia and ThrombosisPlatelet Disorders and TreatmentsComplement system in diseases
Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients | Litcius